drugset / Trial / NCT02715700

Effects of Doravirine (MK-1439) on Methadone Pharmacokinetics in Methadone-Maintained Participants (MK-1439-045)

NCT02715700

Phase 1 Completed 14 enrolled Merck Sharp & Dohme LLC
NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate the effects of multiple doses of doravirine (MK-1439) on the pharmacokinetics of methadone in participants requiring methadone maintenance therapy. The primary hypothesis is that area under the plasma concentration-time curve to 24 hours postdose (AUC0-24) of (R)-methadone is similar when a maintenance regimen of methadone is administered with or without multiple daily doses of doravirine.

Timeline

Start
2015-09-28
Primary completion
2016-06-13
Completion
2016-08-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Doravirine Small molecule 100 mg Oral
Subject Methadone Other / unclassified Oral